Pharmacokinetics of Levodopa and Carbidopa in Rats Following Different Routes of Administration
- 1 January 1994
- journal article
- research article
- Published by Springer Nature in Pharmaceutical Research
- Vol. 11 (4) , 549-555
- https://doi.org/10.1023/a:1018970617104
Abstract
This study examined the pharmacokinetics of levodopa and carbidopa in the rat after different modes of administration. The drugs were given simultaneously by the intravenous, intraarterial, oral, duodenal, and intraperitoneal routes, as single doses. The ratio of levodopa to carbidopa given was always 4:1. Two iv doses (5 and 15 mg/kg of levodopa) were given to test for nonlinearity. Three ip doses of levodopa were given (5, 7.5, and 15 mg/kg), and the 15 mg/kg dose was given in three volumes (2, 4, and 20 mL/kg). One oral dose and two intraduodenal doses of 15 mg/kg were given. The drugs were dissolved in saline in one of the intraduodenal doses and suspended in 1.8% methylcellulose in the other. The elimination of levodopa was nonlinear. There was a comparatively high degree of interindividual variability in absorption with the oral route, but this was substantially reduced when levodopa was given intraduodenally. There was also much less variability with the intraperitoneal route compared to the oral, and the degree of absorption was generally high. There was a significantly higher extent and slower rate of absorption when levodopa was administered ip in a large volume of vehicle. These results suggest that the oral route may not be the optimal method of delivering levodopa to patients who have a fluctuating response and that a continuous delivery system via the intraperitoneal or intraduodenal routes might be a better alternative.Keywords
This publication has 20 references indexed in Scilit:
- Carbidopa dosage modifies L-DOPA induced side effects and blood levels of L-DOPA and other amino acids in advanced parkinsonismActa Neurologica Scandinavica, 2009
- Erratic gastric emptying of levodopa may cause “random” fluctuations of parkinsonian mobilityNeurology, 1988
- Duodenal delivery of levodopa for on‐off fluctuations in parkinsonism: Preliminary observationsAnnals of Neurology, 1986
- Simultaneous assay of 3,4-dihydroxyphenylalanine, catecholamines and O-methylated metabolites in human plasma using high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1984
- Pharmacokinetics of LevodopaClinical Neuropharmacology, 1984
- "ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPYThe Lancet, 1976
- SYNTHETIC AMINO ACIDS AND THE NATURE OF l‐DOPA TRANSPORT AT THE BLOOD‐BRAIN BARRIERJournal of Neurochemistry, 1975
- The role of the liver in the clearance ofl-dopa from plasmaJournal of Pharmacokinetics and Biopharmaceutics, 1975
- Plasma dopa concentrations and the “on‐off” effect after chronic treatment of Parkinson's diseaseNeurology, 1974
- Weitere experimentelle Untersuchungen ber den Catecholaminstoffwechsel bei extrapyramidalen Erkrankungen (Parkinson- und Chorea-Syndrom)Archiv Fur Psychiatrie Und Nervenkrankheiten, 1967